Neuralstem

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Neuralstem and buy or sell other stocks, ETFs, and their options commission-free!

About CUR

Neuralstem, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. 

CEO
CEO
Employees
6
Employees6
Headquarters
Germantown, Maryland
HeadquartersGermantown, Maryland
Founded
1996
Founded1996
Employees
6
Employees6

CUR Key Statistics

Market cap
27.67M
Market cap27.67M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
168.33K
Average volume168.33K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.59
52 Week high$1.59
52 Week low
$0.25
52 Week low$0.25
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.